To fulfill its statutory mandate under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the U.S. Environmental Protection Agency (EPA) should provide information about risk factors for developing cancer, both in terms of individual risk profiles and making the results of the registration and re-registration reviews more accessible to the public. Most people in the United States are unaware of risk factors for developing cancer, and the language of EPA’s registration and re-registration processes for pesticide warning labels remains opaque. By remedying these issues of access to both consumers’ risk profiles for developing cancer and EPA’s own deliberative process for approving pesticide warning labels, EPA can create a regulatory regime in which consumers will have more information with which to choose how they approach using pesticides and pesticide manufacturers are less likely to face failure to warn lawsuits from consumers. These benefits would occur even though the ultimate disposition of the Eleventh Circuit case Carson v. Monsanto, which addresses whether FIFRA overrides state law failure to warn claims, is uncertain.